Agios Pharmaceuticals, Inc. Financial Ratios — AGIO Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-19.25	-30.6	-56.41	-85.73	-65.1	-61.97	-62.95	189.74	-19.37	-36.83	57.29	-30.2
Return on Assets (%)	- -	-12.13	-23.3	-15.44	-25.82	-38.2	-51.02	-46.99	-47.05	-37.55	140.11	-17.32	-32.36	51.82	-27.89
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	54.31	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-32.19	- -
Gross Margin (%)	100	100	100	100	100	100	100	98.52	- -	- -	- -	88.03	89.26	88.59	88.26
EBITDA Margin (%)	-72.49	-86.9	-146.56	-80.73	-195.13	-279.4	-730.89	-376.44	- -	- -	- -	-2,671.93	-1,434.83	-1,150.98	-864.28
Operating Margin (%)	-76.16	-91.59	-152.2	-82.83	-200.78	-287.57	-745.84	-384.03	- -	- -	- -	-2,732.07	-1,459.52	-1,166.47	-873.87
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	-48.96	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-75.56	-91.32	-151.98	-82.51	-199.14	-283.97	-731.6	-366.61	- -	- -	- -	-1,627.82	-1,312.63	1,967.15	-765.89
Profit Margin (%)	-108.56	-80.07	-154.25	-81.86	-199.14	-283.97	-731.6	-366.61	- -	- -	- -	-1,627.82	-1,312.63	1,845.92	-764.01
Net Income to Common Margin (%)	-122.75	-108.71	-170.54	-81.86	-199.14	-283.97	-731.6	-366.61	- -	- -	- -	-1,627.82	-1,312.63	1,845.92	-764.01
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.16	- -
Dvd Payout Ratio (%)	11.56	26.34	9.55	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-19.25	-30.6	-56.41	-85.73	-65.1	-61.97	-62.95	189.74	-19.37	-36.83	57.29	-30.2

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	114	105	97	86	72	57	40
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	7	7	11	14	15	17	18
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	107	98	86	72	57	40	22
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.37	-0.32	-0.26	-0.23	-0.19	-0.14	-0.09
Net Debt/EBITDA	7.43	4.18	1.91	0.27	0.62	0.82	0.33	0.2	0.26	0.39	0.55	0.37	0.23	0.18	0.19
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.36	-0.31	-0.26	-0.22	-0.18	-0.13	-0.09
Net Debt/EBIT	7.07	3.97	1.84	0.26	0.6	0.8	0.32	0.19	0.26	0.38	0.54	0.36	0.23	0.18	0.19
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-18.29	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-19.08	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-18.84	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	18	- -	- -	- -	- -	- -
Common Equity/Total Assets	-27.14	-52.57	65.35	86.27	82.16	57.92	61.12	80.09	71.91	46.84	89.86	88.87	86.54	92.65	91.97
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	16.67	24.48	6.65	6.54	7.03	2.61	1.83
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	14.15	19.38	6.19	6.07	6.45	2.52	1.77
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	11.98	11.46	5.98	5.81	6.08	2.42	1.68
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	17.75	26.33	7.52	7.78	8.88	3.7	3.37
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	15.07	20.84	6.99	7.22	8.15	3.57	3.26
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	12.76	12.33	6.75	6.92	7.68	3.43	3.1
Net Debt to Equity	-186.35	-207.98	-54.43	-3.31	-20.79	-44.83	-27.36	-10.25	-12.64	-31.9	-15.72	-12.65	-10.88	-4.95	-7.47
Net Debt/Capital (%)	215.81	192.61	-119.42	-3.42	-26.25	-81.26	-37.66	-11.43	-12.02	-33.78	-17.13	-13.3	-11.1	-5.01	-7.79
EBITDA	-16	-22	-37	-53	-115	-195	-314	-355	-308	-326	-369	-380	-385	-420	-467
EBITDA-CapEx	-18	-23	-39	-55	-136	-205	-319	-362	-320	-340	-375	-385	-403	-422	-481
Operating Income (Loss)	-17	-23	-39	-54	-119	-201	-321	-362	-316	-336	-378	-389	-391	-426	-472

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	3.72	3.64	4.52	5.6	5.99	6.12	4.47	6.26	6.08	6.07	17.05	12.5	11.43	11.01	10.39
Current Ratio	3.96	3.71	4.6	5.89	6.38	6.33	4.69	6.56	6.59	6.74	17.79	13.3	12.27	11.9	11.46
Quick Ratio	3.72	3.64	4.53	5.81	6.21	6.22	4.5	6.37	6.25	6.07	17.12	12.54	11.47	11.06	10.52
CFO/Avg Current Liab	- -	-1.19	-1.57	-1.21	-1.35	0.55	-3.11	-3.23	-3.98	-3.11	-5.28	-5.05	-4.53	-5.23	-4.57
Common Equity/Total Assets	-27.14	-52.57	65.35	86.27	82.16	57.92	61.12	80.09	71.91	46.84	89.86	88.87	86.54	92.65	91.97
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	16.67	24.48	6.65	6.54	7.03	2.61	1.83
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	14.15	19.38	6.19	6.07	6.45	2.52	1.77
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	11.98	11.46	5.98	5.81	6.08	2.42	1.68
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	17.75	26.33	7.52	7.78	8.88	3.7	3.37
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	15.07	20.84	6.99	7.22	8.15	3.57	3.26
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	12.76	12.33	6.75	6.92	7.68	3.43	3.1
CFO/Total Liabilities	-11.59	-53.21	-80.89	-87.88	-102.67	14.8	-119.4	-178.11	-148.12	-64.12	-279.44	-224.42	-234.79	-318.91	-358.25
CFO/CapEx	-7.98	-33.59	-43.59	-26.78	-3.82	3.89	-61.65	-43.58	-30.81	-20.61	-70.95	-63.4	-16	-231.36	-26.05
Altman's Z-Score	0.32	-0.29	5.92	36.95	18.66	2.92	4.22	7.07	4.98	0.41	7.09	5.91	4.33	8.91	8.2

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	107.34	18.76	8.03	10.66	10.05	13.38	- -	- -	- -	12.91	10.69	10.55	7.36
Days Sales Outstanding	- -	- -	3.4	19.46	45.43	34.24	36.3	27.29	- -	- -	- -	28.27	34.13	34.6	49.61
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	3.22	0.32	0.25	- -	0.4	0.21	0.18	0.21
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	113.52	1,136.29	1,433.26	- -	909.5	1,746.32	2,045.93	1,741.19
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	0.11	0.39	0.51	-0.85	0.58	0.95	0.96	0.67
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	3,273.64	933.17	710.84	-427.43	632.13	384.87	379.55	548.3
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	-3,132.83	- -	- -	- -	305.65	1,395.58	1,700.97	1,242.49
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-86.24	- -	- -	- -	-881.23	-1,712.2	-2,011.33	-1,691.58
Inventories	- -	- -	- -	- -	- -	- -	- -	1	7	15	- -	8	19	28	33
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	1	7	13	- -	8	18	25	30
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	1	1	3	3
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	747	4,157	2,447	1,762	2,791	2,684	3,266	3,003	1,786	1,546	1,246	1,878	1,591
- Cash & Cash Equivalents	118	91	72	14	72	161	103	71	81	127	203	139	88	76	89
+ Preferred Equity and Hybrid Capital	116	116	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	114	105	97	86	72	57	40
Enterprise Value	-63	-12	581	3,815	2,130	1,221	2,367	2,099	2,815	2,535	863	848	541	1,041	777
Total Capital	63	44	131	424	345	359	376	688	754	505	1,389	1,186	883	1,598	1,233
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	15.07	20.84	6.99	7.22	8.15	3.57	3.26
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.04	0.04	0.11	0.1	0.13	0.05	0.05
EV/Sales	- -	- -	22.72	58.37	36.03	17.46	55.04	22.24	- -	- -	- -	59.55	20.17	28.53	14.38
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	31.65	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	25.18	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	369	3,772	2,430	1,633	2,663	2,648	2,865	2,990	1,987	1,538	1,239	1,902	1,578
Diluted Enterprise Value	-2	25	298	3,758	2,358	1,472	2,561	2,577	2,897	2,967	1,881	1,485	1,223	1,883	1,529
EV per Share	- -	- -	18.61	102.82	56.51	28.91	48.49	36.06	41.15	36.58	15.88	15.41	9.67	18.22	13.29
TTM Sales	22	25	26	65	59	70	43	94	- -	- -	- -	14	27	36	54
TTM EBITDA	-16	-22	-37	-53	-115	-195	-314	-355	-308	-326	-369	-380	-385	-420	-467
TTM Operating Income	-17	-23	-39	-54	-119	-201	-321	-362	-316	-336	-378	-389	-391	-426	-472
TTM Cash Flow to Firm	-15	-50	-56	-59	-77	39	-285	-304	-371	-273	-407	-309	-296	-390	-373
TTM Free Cash Flow to Firm	-13	-48	-55	-57	-57	48	-281	-297	-359	-259	-402	-305	-278	-388	-359

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-6.7	-66.02	-42.79	33.68	-9.49	-8.9	-7.99	-10.81	-4.95	-5.05	-4.47	-4.9	-4.4
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-63	-12	581	3,815	2,130	1,221	2,367	2,099	2,815	2,535	863	848	541	1,041	777
Low Price	- -	- -	15.77	21.7	48	33.5	39.24	41.63	28.36	27.77	29.21	16.75	19.8	20.96	22.24
EV/Sales	- -	- -	22.72	58.37	36.03	17.46	55.04	22.24	- -	- -	- -	59.55	20.17	28.53	14.38
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.24	- -	- -	2.77	- -
Price/Earnings Average	- -	- -	-8.79	-32.67	-30.37	-9.28	-8.22	-12.73	-6.94	-9.26	1.83	-6.39	-3.96	3.29	-4.79
Price/Earnings High	- -	- -	-11.88	-78.27	-44.14	-13.35	-10.77	-16.56	-10.05	-11.96	2.34	-8.3	-4.99	5.28	-6.46
Price/Earnings Low	- -	- -	-5.58	-13.65	-15.26	-6.6	-5.81	-6.91	-4.14	-5.85	1.1	-3.96	-3.13	1.77	-3.12
Price/Book Value	- -	- -	5.68	9.8	7.09	4.91	7.43	3.9	5.1	7.52	1.38	1.4	1.54	1.22	1.33
Price/Book Value Average	- -	- -	5.9	4.54	10.43	5.54	7.22	6.5	5.08	7.62	2.04	1.35	1.73	1.45	1.67
Price/Book Value High	- -	- -	7.97	10.87	15.17	7.98	9.46	8.45	7.36	9.84	2.61	1.76	2.18	2.32	2.25
Price/Book Value Low	- -	- -	3.74	1.9	5.24	3.94	5.1	3.53	3.03	4.82	1.23	0.84	1.37	0.78	1.09
Price/Tangible Book Value	- -	- -	5.68	9.8	7.09	4.91	7.43	3.9	5.1	7.52	1.38	1.4	1.54	1.22	1.33
Price/Tangible Book Value Average	- -	- -	5.9	4.54	10.43	5.54	7.22	6.5	5.08	7.62	2.04	1.35	1.73	1.45	1.67
Price/Tangible Book Value High	- -	- -	7.97	10.87	15.17	7.98	9.46	8.45	7.36	9.84	2.61	1.76	2.18	2.32	2.25
Price/Tangible Book Value Low	- -	- -	3.74	1.9	5.24	3.94	5.1	3.53	3.03	4.82	1.23	0.84	1.37	0.78	1.09
Price/Sales	- -	- -	14.45	57.71	41.1	23.36	61.92	28.05	- -	- -	- -	108.04	46.21	51.15	29.21
Price/Sales Average	- -	- -	15	26.74	60.48	26.35	60.16	46.66	- -	- -	- -	104.04	52.02	60.66	36.58
Price/Sales High	- -	- -	20.27	64.08	87.91	37.92	78.78	60.73	- -	- -	- -	135.13	65.48	97.4	49.36
Price/Sales Low	- -	- -	9.52	11.18	30.39	18.75	42.5	25.32	- -	- -	- -	64.45	41.07	32.62	23.86
Price/Cash Flow	- -	- -	-6.55	-63.55	-31.58	42.34	-9.34	-8.7	-7.73	-10.28	-4.88	-4.97	-4.19	-4.79	-4.23
Price/Cash Flow Average	- -	- -	-6.79	-29.45	-46.47	47.76	-9.07	-14.47	-7.7	-10.43	-7.19	-4.79	-4.71	-5.68	-5.3
Price/Cash Flow High	- -	- -	-9.18	-70.56	-67.54	68.73	-11.88	-18.83	-11.16	-13.47	-9.22	-6.22	-5.93	-9.12	-7.15
Price/Cash Flow Low	- -	- -	-4.31	-12.31	-23.35	33.99	-6.41	-7.85	-4.59	-6.59	-4.33	-2.97	-3.72	-3.05	-3.46
Price/Free Cash Flow Average	- -	- -	-6.95	-30.59	-62.97	37.99	-9.22	-14.81	-7.96	-10.96	-7.29	-4.86	-5.03	-5.81	-5.51
Price/Free Cash Flow High	- -	- -	-9.4	-73.29	-91.52	54.67	-12.08	-19.27	-11.53	-14.15	-9.36	-6.32	-6.33	-9.33	-7.44
Price/Free Cash Flow Low	- -	- -	-4.41	-12.79	-31.64	27.04	-6.51	-8.04	-4.74	-6.93	-4.4	-3.01	-3.97	-3.13	-3.59
EV/Sales Average	- -	0.98	27.55	29.25	59.7	26.13	60.66	46.56	- -	- -	- -	100.75	51.69	60.5	35.97
EV/Sales High	- -	0.98	38.22	70.4	87.32	38.62	80.17	60.83	- -	- -	- -	131.98	65.22	97.47	48.86
EV/Sales Low	- -	0.98	16.46	12.1	29.39	17.94	42.16	24.93	- -	- -	- -	60.98	40.68	32.3	23.15
EV/EBITDA Average	0.11	-1.13	-18.8	-36.23	-30.6	-9.35	-8.3	-12.37	-10.66	-9.27	-6.84	-3.77	-3.6	-5.26	-4.16
EV/EBITDA High	0.11	-1.13	-26.08	-87.19	-44.75	-13.82	-10.97	-16.16	-15.41	-11.99	-8.86	-4.94	-4.55	-8.47	-5.65
EV/EBITDA Low	0.11	-1.13	-11.23	-14.99	-15.06	-6.42	-5.77	-6.62	-6.4	-5.83	-4.01	-2.28	-2.84	-2.81	-2.68
EV/EBIT Average	0.1	-1.07	-18.1	-35.32	-29.73	-9.09	-8.13	-12.13	-10.39	-9	-6.68	-3.69	-3.54	-5.19	-4.12
EV/EBIT High	0.1	-1.07	-25.11	-84.99	-43.49	-13.43	-10.75	-15.84	-15.01	-11.64	-8.64	-4.83	-4.47	-8.36	-5.59
EV/EBIT Low	0.1	-1.07	-10.81	-14.61	-14.64	-6.24	-5.65	-6.49	-6.24	-5.66	-3.91	-2.23	-2.79	-2.77	-2.65
Last Price	- -	- -	23.95	112.04	64.92	41.73	57.17	46.11	47.75	43.33	32.87	28.08	22.27	32.86	27.22
High Price	- -	- -	33.59	124.39	138.85	67.74	72.73	99.82	68.94	56.74	62.16	35.12	31.56	62.58	46
Enterprise Value Average	-2	25	704	1,912	3,529	1,827	2,609	4,395	3,287	3,023	2,527	1,435	1,386	2,208	1,944
Enterprise Value High	-2	25	977	4,601	5,162	2,699	3,448	5,741	4,748	3,910	3,271	1,879	1,749	3,558	2,640
Enterprise Value Low	-2	25	421	791	1,738	1,254	1,813	2,353	1,973	1,902	1,481	868	1,091	1,179	1,251

Shares Outstanding	30	30	31	37	38	42	49	58	68	69	54	55	56	57	58
Diluted Weighted Avg Shares	23	23	15	34	37	39	47	57	60	69	60	55	56	58	58
Basic Weighted Avg Shares	23	23	15	34	37	39	47	57	60	69	60	55	56	57	58
Revenue per Share	0.93	1.07	1.66	1.94	1.58	1.79	0.92	1.64	- -	- -	- -	0.26	0.48	0.64	0.93
EBITDA per Share	-0.68	-0.93	-2.43	-1.57	-3.08	-4.99	-6.75	-6.19	-5.14	-4.73	-6.11	-6.94	-6.92	-7.39	-8.05
Operating Income per Share	-0.71	-0.98	-2.52	-1.61	-3.17	-5.14	-6.89	-6.31	-5.27	-4.87	-6.26	-7.1	-7.03	-7.49	-8.14
Basic EPS, GAAP	-1.15	-1.17	-2.83	-1.59	-3.15	-5.07	-6.75	-6.03	-6.86	-4.74	26.55	-4.23	-6.33	11.86	-7.12
Basic EPS from Cont Ops	-1.01	-0.86	-2.56	-1.59	-3.15	-5.07	-6.75	-6.03	-5.02	-4.77	-5.9	-4.23	-6.33	11.86	-7.12
Diluted EPS, GAAP	-1.15	-1.17	-2.83	-1.59	-3.15	-5.07	-6.75	-6.03	-6.86	-4.74	26.55	-4.23	-6.33	11.64	-7.12
Diluted EPS from Cont Ops	-1.01	-0.86	-2.56	-1.59	-3.15	-5.07	-6.75	-6.03	-5.02	-4.77	-5.9	-4.23	-6.33	11.64	-7.12
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.65	-2.12	-3.66	-1.76	-2.06	0.99	-6.12	-5.3	-6.18	-4.21	-6.74	-5.65	-5.32	-6.86	-6.43
Free Cash Flow per Basic Share	-0.73	-2.18	-3.74	-1.83	-2.59	0.73	-6.22	-5.42	-6.38	-4.42	-6.83	-5.74	-5.65	-6.89	-6.68
Cash & Equivalents per Share	5.95	4.25	5.34	9.22	8.41	12.82	8.68	10.05	8.26	8.27	18.77	14.23	13.89	15.64	14.62
Book Value per Share	-1.75	-2.39	4.21	11.44	9.16	8.49	7.69	11.81	9.36	5.77	23.78	20	14.5	26.96	20.41
Tangible Book Value per Share	-1.75	-2.39	4.21	11.44	9.16	8.49	7.69	11.81	9.36	5.77	23.78	20	14.5	26.96	20.41

Agios Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)